Table 21.

Expression profiles of ligands in tumor cells from the AML patients

	AML-1	AML-2	AML-3	AML-4	AML-5
MIC-A	1.78	8.70	2.32	2.33	1.00
MIC-B	2.59	6.40	2.61	3.08	1.00
B7–H6	0.79	1.03	1.52	0.82	1.20
ULBP1	2.48	8.85	3.29	3.36	1.00
ULBP3	1.45	8.21	2.52	2.49	1.00
ULBP4	0.83	0.97	1.61	3.38	0.98
DR4	3.04	8.25	4.35	4.08	1.45
DR5	0.83	2.18	2.43	2.51	1.24
PCNA	1.68	4.96	1.43	1.71	1.40
HLA-C	0.87	2.80	11.61	2.42	3.69
HLA-G	50.35	172.68	37.46	3.74	2.41
CD200	55.92	3.30	22.21	27.73	8.68
CD155	52.14	110.83	93.55	39.75	2.17
CA125	5.54	4.28	6.96	3.28	5.79
CD58	75.08	83.48	289.27	31.81	47.62
CD112	2.10	1.31	21.40	30.03	1.71